Auriga Partners is a Paris-based company founded in 1998 by Bernard Daugeras, Jacques Chatain, Patrick Bamas and Patricia Roisain.
Auriga Partners has made investments in Exeliom, Flash Therapeutics, EnobraQ, Pherecydes Pharma, aveni, Vectalys, VitaDX, Nosopharm, TxCell, One More Company, Nexthink, Pylote and CoLucid Pharmaceuticals.
They exited their investments in Innate Pharma, Ekinops, Genocea Biosciences, Median Technologies, Gamida Cell, Neolane, TiGenix, CellNovo, SuperSonic Imagine, Eptica and Wallix.
Auriga Partners raised their Auriga IV Bioseeds fund for a total of €42.3 million. This fund was announced on Nov 19, 2013.